Cargando…
OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model
Dominant optic atrophy (DOA) is a rare progressive and irreversible blinding disease which is one of the most frequent forms of hereditary optic neuropathy. DOA is mainly caused by dominant mutation in the OPA1 gene encoding a large mitochondrial GTPase with crucial roles in membrane dynamics and ce...
Autores principales: | Sarzi, Emmanuelle, Seveno, Marie, Piro-Mégy, Camille, Elzière, Lucie, Quilès, Mélanie, Péquignot, Marie, Müller, Agnès, Hamel, Christian P., Lenaers, Guy, Delettre, Cécile |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802757/ https://www.ncbi.nlm.nih.gov/pubmed/29410463 http://dx.doi.org/10.1038/s41598-018-20838-8 |
Ejemplares similares
-
Dominant mutations in mtDNA maintenance gene SSBP1 cause optic atrophy and foveopathy
por: Piro-Mégy, Camille, et al.
Publicado: (2019) -
Dominant optic atrophy
por: Lenaers, Guy, et al.
Publicado: (2012) -
Gene structure and chromosomal localization of mouse Opa1 : its exclusion from the Bst locus
por: Delettre, Cécile, et al.
Publicado: (2003) -
Autophagy controls the pathogenicity of OPA1 mutations in dominant optic atrophy
por: Kane, Mariame Selma, et al.
Publicado: (2017) -
ACO2 mutations: A novel phenotype associating severe optic atrophy and spastic paraplegia
por: Marelli, Cecilia, et al.
Publicado: (2018)